Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Cancer Discov. 2015 Jul 15;5(9):944–959. doi: 10.1158/2159-8290.CD-15-0090

Figure 6. MYC-HOXB7-HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen.

Figure 6

Kaplan-Meier plots of overall survival probability in endocrine therapy treated breast cancer patients with ER+ tumors (n=1208) expressing A, HOXB7 B, HOXB7 and HER2 and C, HOXB7, HER2, and MYC.